A Clinical Trial to Investigate Safety and Tolerability of ASP7962 in Healthy Humans

Clinical trial NCT01981928 · COMPLETED

Trial details

NCT number: NCT01981928
Sponsor: Astellas Pharma Europe B.V.
Status: COMPLETED
Phase: Phase 1
Study type: INTERVENTIONAL

Safety Tolerability Pharmacokinetics of ASP7962

Start date: 2013-11-01
Primary completion: 2014-05-01
Enrollment: 48

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.